Briefing: Oil prices walk back gains as G7 nations consider tapping emergency oil reserves
Strategic angle: The U.S. ordered non-emergency government staff to leave Saudi Arabia as the widening Iran war rattled markets and sent oil prices surging above $110 per barrel.
Briefing: Opetaia out to unify cruiserweight division after winning Zuffa belt
Strategic angle: Jai Opetaia breezed past Brandon Glanton to become the inaugural Zuffa world cruiserweight champion with a unanimous-decision win in Nevada.
Briefing: European leaders set for emergency talks as Iran war enters day 10
Strategic angle: Tune in to Euronews' new flagship morning programme at 8 am Brussels time for the latest updates.
Briefing: US Court of Appeals: TOS may be updated by email, use can imply consent
Strategic angle: A recent ruling clarifies that terms of service can be modified via email, and user engagement may indicate agreement.
Can a taxpayer-funded European social media platform work?
A group of activists is urging the European Commission to support the creation of a European social network funded by civil society.
Strategic view: McGuigan: 'People overlooking how good Scotney is. She's phenomenal'
Strategic implications in focus: Ellie Scotney is on the edge of greatness, says boxing legend Barry McGuigan.
Briefing: Germany seeks to emulate Japan in shoring up critical minerals
Strategic angle: BMW and Rheinmetall push for joint purchasing of raw materials to reduce reliance on China
Briefing: Think geopolitics is bad? Look at geoeconomics
Strategic angle: Markets suggest the Iran ramifications are likely to drag on and spread.
Briefing: Which economies will pay the biggest price for the Iran war?
Strategic angle: American consumers will feel pain at the petrol pump, but US is a net energy exporter unlike its European allies.
Strategic view: Japan rallies past Australia, clinches WBC group
Strategic implications in focus: Defending champion Japan rallied from 1-0 down to beat Australia 4-3 in the World Baseball Classic on Sunday behind a two-run homer from Masataka Yoshida with two outs in the seventh inning.
Strategic view: MLB Free Agent Tracker: Top 50 FAs Signings for 2026 Season
Strategic implications in focus: Here are the latest signings from baseball's hot stove as spring training camps continue.
Strategic view: Serbia: Fears rise over the last independent media outlets
Strategic implications in focus: Concerns grow over potential shifts in media independence following a deal with a state-owned telecommunications company.
Ibrox Incident Signals Underlying Tensions in Scottish Football Rivalry
The pitch invasion at Ibrox after Celtic's win reveals deeper issues within fan engagement and security in Scottish football.
Strategic view: Jim Cramer on Howmet Aerospace: “It’s Just in The Sweet Spot”
Strategic implications in focus: Jim Cramer discusses the promising outlook for Howmet Aerospace.
Strategic view: Jim Cramer on AeroVironment, Inc.: “It’s a Long-time Cramer Fave, But Things Don’t Seem Right Here”
Strategic implications in focus: Jim Cramer expresses concerns about AeroVironment, Inc., despite its long-standing popularity.
Strategic view: 5 Lessons from Vinay Prasad’s Turbulent Tenure at the FDA
Strategic implications in focus: Vinay Prasad's unique ability to attract criticism — even when his bosses, including the president, wanted him to keep his head low — did him in at the FDA.
Cancellation of Federal Autism Advisory Board Meeting Signals Operational Challenges
The cancellation of the first public meeting of the federal autism advisory board, post-reconstitution, highlights potential operational inefficiencies and stakeholder engagement risks.
Strategic view: China Really Thinks It Is Just Defending Itself
Strategic implications in focus: That’s what makes it so dangerous.
Rivian's 2026 R2 Production Goal: A High-Stakes Move
Rivian's ambition to produce 20,000 R2 units by 2026 positions it against formidable competition, notably the Tesla Model Y, which achieved this milestone faster.
Strategic view: FDA's Controversial Actions Against UniQure Raise Political Concerns
Strategic implications in focus: Recent FDA decisions could complicate the Trump administration's relationship with drugmaker UniQure.